📰 Daniel Bohsen News
Daniel Bohsen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Daniel Bohsen. Real-time updates on events, politics, business and more.
May 3, 2024
Novo Nordisk A/S misses on earnings expectations. Reported EPS is $0.7 EPS, expectations were $0.77.
May 2, 2024
NVO earnings call for the period ending March 31, 2024.
February 1, 2024
Novo Nordisk A/S (NYSE:NVO) Q4 2023 Earnings Call Transcript January 31, 2024 Novo Nordisk A/S beats earnings expectations. Reported EPS is $4.91, expectations were $0.66. NVO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for […]
February 1, 2024
Novo Nordisk A/S beats earnings expectations. Reported EPS is $4.91, expectations were $0.66.
January 31, 2024
NVO earnings call for the period ending December 31, 2023.
January 31, 2024
NVO earnings call for the period ending December 31, 2023.
January 16, 2024
We’ve all read the stories: the success of Novo Nordisk’s diabetes-turned-weight-loss drugs driving a 53 percent share increase
January 12, 2024
As 2024 gets underway, IROs are already grappling with the issues that will define the next 12 months for them.
November 4, 2023
Operator: Good day and thank you for standing by. Welcome to the Q3 2023 Novo Nordisk A/S Earnings Conference Call. At this time, all participants are in a listen-only mode.
November 4, 2023
Novo Nordisk A/S (NYSE:NVO) Q3 2023 Earnings Call Transcript November 2, 2023 Novo Nordisk A/S beats earnings expectations. Reported EPS is $5.01, expectations were $0.6. Operator: Good day and thank you for standing by. Welcome to the Q3 2023 Novo Nordisk A/S Earnings Conference Call. At this time, all participants are in a listen-only mode. […]